Intellectia LogoIntellectia
Stock
Crypto
Features
Resources
Company
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo
StockCrypto

Features

Pre Market Movers
Financial AI Agent
Swing Trading
Stock Technical Analysis
Stock Monitor
Copy Top Investors Portfolio
Crypto Technical Analysis
Chart Pattern Signal

Resources

Blog
Earnings
Partner Program

Company

Contact
About
News Release
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. CVS
    4. >
  4. Forecast

Stock Price Prediction

-
stocks logo
CVS
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

CVS Price Prediction Next Week

Technical Analysis: Based on the latest price data, CVS is currently trading at $52.65, showing a positive momentum with a 1.27% gain in the last trading session . The RSI(14) at 62.84 indicates the stock is approaching but not yet in overbought territory.

The Fibonacci levels suggest:

  • Resistance levels: R1 at $52.06, R2 at $54.13, R3 at $57.47
  • Support levels: S1 at $45.37, S2 at $43.31, S3 at $39.96
  • Pivot point: $48.72

News Impact: Recent news has mixed implications for CVS:

  • Positive: CVS is mentioned as a key tenant in Realty Income's portfolio, highlighting its stability as a reliable retail tenant.
  • Negative: The healthcare sector faced pressure after UnitedHealth's disappointing Q4 results, which affected CVS's stock performance.

Price Prediction for Next Week: Based on technical indicators and news sentiment:

  • Bullish case (60% probability): Price likely to test R1 at $52.06 and potentially break through to R2 at $54.13
  • Bearish case (40% probability): May retrace to the 20-day SMA at $46.77

Trading Recommendation: BUY with the following parameters:

  • Entry: Current price ($52.65)
  • Target: $54.13 (R2 level)
  • Stop loss: $51.79 (last session's low)
  • Risk/Reward ratio: 1:1.5

The recommendation is based on:

  1. Positive momentum from last trading session
  2. RSI showing strength but not overbought
  3. Price trading above key moving averages (20-day SMA at $46.77)
  4. Strong support from Fibonacci levels

Technical Analysis: Based on the latest price data, CVS is currently trading at $52.65, showing a positive momentum with a 1.27% gain in the last trading session . The RSI(14) at 62.84 indicates the stock is approaching but not yet in overbought territory.

The Fibonacci levels suggest:

  • Resistance levels: R1 at $52.06, R2 at $54.13, R3 at $57.47
  • Support levels: S1 at $45.37, S2 at $43.31, S3 at $39.96
  • Pivot point: $48.72

News Impact: Recent news has mixed implications for CVS:

  • Positive: CVS is mentioned as a key tenant in Realty Income's portfolio, highlighting its stability as a reliable retail tenant.
  • Negative: The healthcare sector faced pressure after UnitedHealth's disappointing Q4 results, which affected CVS's stock performance.

Price Prediction for Next Week: Based on technical indicators and news sentiment:

  • Bullish case (60% probability): Price likely to test R1 at $52.06 and potentially break through to R2 at $54.13
  • Bearish case (40% probability): May retrace to the 20-day SMA at $46.77

Trading Recommendation: BUY with the following parameters:

  • Entry: Current price ($52.65)
  • Target: $54.13 (R2 level)
  • Stop loss: $51.79 (last session's low)
  • Risk/Reward ratio: 1:1.5

The recommendation is based on:

  1. Positive momentum from last trading session
  2. RSI showing strength but not overbought
  3. Price trading above key moving averages (20-day SMA at $46.77)
  4. Strong support from Fibonacci levels

CVS Similar Chart Price Prediction

The price of CVS is predicted to go up -13.56%, based on the high correlation periods with TTI. The similarity of these two price pattern on the periods is 97.66%.

stocks logo

CVS

stocks logo

TTI

Down: -13.56%Similarity: 97.66%

CVS Stock Forecast & Prediction For Years 2025, 2026, 2027, 2028, 2029 and 2030

Year

CVS Price Forecast($)

Potential Return(%)

2025

55.000

14.510

2026

60.000

24.920

2027

65.000

35.330

2028

65.000

35.330

2029

65.000

35.330

2030

65.000

35.330

What is CVS stock price prediction 2025 ?

CVS stock is predicted to reach $55-$60 by the end of 2025, assuming moderate recovery driven by restructuring efforts and improved operational efficiency under new leadership. The stock's current undervaluation (P/E ~7) and potential strategic shifts, such as divestitures, could unlock shareholder value. However, risks remain due to past performance issues and uncertain execution of turnaround plans.

What is CVS stock price prediction 2026 ?

CVS stock is predicted to reach $60 by 2026, reflecting a moderate recovery. This projection is based on expected operational improvements under new management, cost-cutting measures, and higher pricing for Medicare Advantage plans, which could stabilize margins. However, risks remain due to regulatory uncertainties and potential restructuring challenges.

What is CVS stock price prediction 2027 ?

CVS stock is projected to reach approximately $65 by 2027, assuming a moderate recovery in its business operations and cost-cutting measures. This estimate is based on its current valuation, expected EPS growth, and potential restructuring benefits. However, risks such as regulatory challenges and competitive pressures could limit upside potential.

What is CVS stock price prediction 2028 ?

CVS stock is predicted to reach $65 by 2028. This projection is based on expected operational improvements under new leadership, cost-cutting measures, and potential restructuring to unlock shareholder value. However, risks such as regulatory challenges and uncertain earnings growth could limit upside potential.

What is CVS stock price prediction 2029 ?

CVS stock is predicted to reach approximately $65 by 2029. This projection is based on anticipated operational improvements under new management, cost-cutting measures, and potential restructuring, which could unlock shareholder value. However, risks remain due to regulatory pressures and uncertainties in its healthcare segments.

What is CVS stock price prediction 2030 ?

CVS stock is predicted to reach approximately $65 by 2030. This projection is based on expected operational improvements under new leadership, cost-cutting measures, and potential restructuring, alongside a modest recovery in healthcare margins. However, regulatory risks and competitive pressures may limit upside potential.

CVS Revenue Forecast

CVS EPS Forecast

CVS FAQs

What is bull‘s view on CVS?

CVS stock is currently trading at $45.78, with analysts projecting a potential upside to $60, supported by a "Strong Buy" rating from Truist Securities. The bullish view stems from CVS's strong cash flow generation and valuation at a forward P/E of 7.46, which is attractive compared to industry peers. Additionally, strategic cost-cutting measures and restructuring efforts under new leadership are expected to improve margins and drive recovery in 2025.

What is bear's view on CVS?

CVS stock is currently bearish, trading at $45.78, down significantly from its 2024 highs. The stock faces challenges including a 43% drop in 2024, weak earnings visibility, and operational struggles, with analysts advising caution until the new CEO's strategy is clearer. Key support levels have broken, and further downside is likely unless significant restructuring or operational improvements materialize.

What is CVS revenue forecast for next quarter？

The market consensus for CVS's revenue in the upcoming quarter is projected to be approximately $93.18B USD.

What is CVS eps forecast for next quarter？

The market consensus for CVS's eps in the upcoming quarter is projected to be approximately $1.471 USD.

CVS VS S&P500

CVS' diverse operations create the opportunity to view a patient more holistically by managing both medical and pharmacy benefits, which could lead to revenue and cost synergies for the organization.

The firm's entry into provider services has the potential to improve returns for all of CVS' segments if it can help patients more easily and cost-effectively manage chronic conditions through early intervention.

CVS' PBM remains an industry leader due to its intense focus on pharmaceutical cost trends that should continue to attract clients.

Ask Intellectia about CVS

CVS Analyst's Forecast

David Macdonald

Truist Securities

Strong Buy

Price Target

$67 → $60

Upside

+30.95%

Truist analyst David MacDonald lowered the firm's price target on CVS Health to $60 from $67 and keeps a Buy rating on the shares as part of a broader research note previewing 2025 for Healthcare Services. The firm sees the outlook for the group as "mixed", with bullish stance on the underlying demand drivers and overarching sector tailwinds that include demographics, value-based care, and core demand being offset by heightened concern around a likely more cost focused government backdrop. Selectivity is key and cash flow generation with broadly attractive financial flexibility are set to provide solid support, while the recent valuation re-rating for several names provides a better setup around risk/reward, the analyst tells investors in a research note.
George Hill

Deutsche Bank

Hold → Strong Buy

Price Target

$66

Upside

+11.51%

Charles Ryhee

TD Cowen

Strong Buy

Price Target

$73 → $80

Upside

+33.11%

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2024 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Product
PricingPre Market MoversFinancial AI AgentSwing TradingStock Technical AnalysisStock MonitorCopy Top Investors PortfolioCrypto Technical Analysis
Support
BlogEarningsTerms of UsePrivacy PolicySitemapPartner Program
Start for Free